Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm

An 84-year-old Japanese man was diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN). We administered combination therapy using venetoclax and azacytidine. We observed neutropenia (Grade 4), thrombocytopenia (Grade 2), and stomatitis (Grade 3). After six cycles of treatment, the BPDCN...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagate, Yasuhiro, Nakaya, Aya, Kamimura, Ren, Hirose, Yumiko, Nojima, Satoshi, Fujita, Jiro, Kiyohara, Eiji, Shibayama, Hirohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518555/
https://www.ncbi.nlm.nih.gov/pubmed/37661416
http://dx.doi.org/10.2169/internalmedicine.0318-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518555/
https://www.ncbi.nlm.nih.gov/pubmed/37661416
http://dx.doi.org/10.2169/internalmedicine.0318-22

Ejemplares similares